Total Payments
$2,301
2022 Payments
$158.18
Companies
19
Transactions
67
Medicare Patients
2,239
Medicare Billing
$280,435
Payment Breakdown by Category
Research$1,204 (52.3%)
Food & Beverage$1,097 (47.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Unspecified | $1,204 | 2 | 52.3% |
| Food and Beverage | $1,097 | 65 | 47.7% |
Payments by Type
Research
$1,204
2 transactions
General
$1,097
65 transactions
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Eli Lilly and Company | $1,204 | 2 | $0 (2021) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $237.59 | 10 | $0 (2022) |
| Novo Nordisk Inc | $113.32 | 10 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $111.79 | 7 | $0 (2020) |
| Teva Pharmaceuticals USA, Inc. | $104.51 | 7 | $0 (2020) |
| Amgen Inc. | $78.43 | 4 | $0 (2022) |
| Astellas Pharma US Inc | $63.22 | 3 | $0 (2019) |
| Edwards Lifesciences Corporation | $60.97 | 3 | $0 (2021) |
| PFIZER INC. | $54.26 | 4 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $45.86 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $158.18 | 4 | Boehringer Ingelheim Pharmaceuticals, Inc. ($98.68) |
| 2021 | $712.87 | 2 | Eli Lilly and Company ($700.00) |
| 2020 | $675.25 | 11 | Eli Lilly and Company ($504.33) |
| 2019 | $726.26 | 48 | Boehringer Ingelheim Pharmaceuticals, Inc. ($138.91) |
| 2018 | $28.44 | 2 | Teva Pharmaceuticals USA, Inc. ($15.20) |
All Payment Transactions
67 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/08/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $98.68 | General |
| Category: DIABETES | ||||||
| 08/10/2022 | Amgen Inc. | EVENITY (Biological) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Bone Health | ||||||
| 07/28/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $22.57 | General |
| Category: ETONOGESTREL | ||||||
| 07/28/2022 | Organon LLC | NEXPLANON (Drug) | Food and Beverage | In-kind items and services | $18.81 | General |
| Category: ETONOGESTREL | ||||||
| 08/30/2021 | Eli Lilly and Company | — | — | Cash or cash equivalent | $700.00 | Research |
| Study: A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS | ||||||
| 04/22/2021 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Ultra Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $12.87 | General |
| Category: Transcatheter Heart Valves | ||||||
| 09/28/2020 | Eli Lilly and Company | — | — | In-kind items and services | $504.33 | Research |
| Study: A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS | ||||||
| 09/10/2020 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $25.95 | General |
| Category: Transcatheter Heart Valves | ||||||
| 03/10/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $12.32 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 03/02/2020 | Edwards Lifesciences Corporation | Edwards SAPIEN 3 Transcatheter Heart Valve (Device) | Food and Beverage | In-kind items and services | $22.15 | General |
| Category: Transcatheter Heart Valves | ||||||
| 02/25/2020 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $16.22 | General |
| Category: NEUROSCIENCE | ||||||
| 02/19/2020 | Merck Sharp & Dohme Corporation | ROTATEQ (Biological), PNEUMOVAX 23, VAQTA | Food and Beverage | In-kind items and services | $12.83 | General |
| Category: VACCINE | ||||||
| 02/18/2020 | Amgen Inc. | Aimovig (Biological), Repatha | Food and Beverage | In-kind items and services | $16.15 | General |
| Category: Neuroscience | ||||||
| 02/12/2020 | Janssen Pharmaceuticals, Inc | XARELTO (Drug), INVOKANA | Food and Beverage | In-kind items and services | $19.25 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 02/04/2020 | Teva Pharmaceuticals USA, Inc. | AJOVY (Biological) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: Central Nervous System | ||||||
| 01/27/2020 | PFIZER INC. | CHANTIX (Drug), EUCRISA, COLOGUARD | Food and Beverage | In-kind items and services | $16.65 | General |
| Category: NEUROSCIENCE;TOBACCO DEPENDENCE | ||||||
| 01/07/2020 | Novartis Pharmaceuticals Corporation | AIMOVIG (Biological) | Food and Beverage | In-kind items and services | $15.42 | General |
| Category: NEUROSCIENCE | ||||||
| 12/17/2019 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.79 | General |
| Category: CNS | ||||||
| 12/11/2019 | AstraZeneca Pharmaceuticals LP | SYMBICORT (Drug) | Food and Beverage | In-kind items and services | $16.64 | General |
| Category: Respiratory | ||||||
| 11/12/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $3.95 | General |
| Category: DIABETES | ||||||
| 10/22/2019 | Astellas Pharma US Inc | MYRBETRIQ (Drug) | Food and Beverage | In-kind items and services | $22.93 | General |
| Category: UROLOGY | ||||||
| 10/16/2019 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug), GLYXAMBI | Food and Beverage | In-kind items and services | $3.92 | General |
| Category: DIABETES | ||||||
| 10/15/2019 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.38 | General |
| Category: Bone Health | ||||||
| 10/08/2019 | Janssen Pharmaceuticals, Inc | INVOKANA (Drug) | Food and Beverage | In-kind items and services | $14.70 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 10/04/2019 | PFIZER INC. | PREVNAR - 13 (Biological) | Food and Beverage | In-kind items and services | $12.75 | General |
| Category: VACCINES | ||||||
Research Studies & Clinical Trials
| Study Name | Company | Amount | Records |
|---|---|---|---|
| A RANDOMIZED, DOUBLE BLIND, PLACEBO CONTROLLED, PHASE 2 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF LY3819253 AND LY3832479 IN PARTICIPANTS WITH MILD TO MODERATE COVID-19 ILLNESS | Eli Lilly and Company | $1,204 | 2 |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 13 | 530 | 1,623 | $229,858 | $76,114 |
| 2021 | 18 | 886 | 2,885 | $226,559 | $116,572 |
| 2020 | 17 | 823 | 2,025 | $192,807 | $87,749 |
Total Patients
2,239
Total Services
6,533
Medicare Billing
$280,435
Procedure Codes
48
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 172 | 220 | $75,900 | $19,840 | 26.1% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 111 | 134 | $64,990 | $18,360 | 28.3% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 14 | 1,020 | $34,680 | $17,046 | 49.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 59 | 59 | $20,886 | $8,623 | 41.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 18 | 19 | $10,773 | $5,320 | 49.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 29 | 29 | $7,105 | $1,767 | 24.9% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2022 | 13 | 13 | $7,683 | $1,299 | 16.9% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2022 | 17 | 17 | $1,105 | $1,091 | 98.7% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 25 | 25 | $3,850 | $1,076 | 27.9% |
| G0009 | Administration of pneumococcal vaccine | Office | 2022 | 22 | 23 | $690.00 | $693.73 | 100.5% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 17 | 17 | $510.00 | $511.96 | 100.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2022 | 15 | 26 | $1,014 | $286.04 | 28.2% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 18 | 21 | $672.00 | $202.03 | 30.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 237 | 389 | $75,855 | $38,452 | 50.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2021 | 18 | 1,800 | $61,200 | $29,258 | 47.8% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 103 | 127 | $32,004 | $17,138 | 53.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2021 | 86 | 86 | $19,178 | $12,622 | 65.8% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 30 | 30 | $11,130 | $4,504 | 40.5% |
| 90662 | Vaccine for influenza for injection into muscle, split virus, preservation free | Office | 2021 | 61 | 61 | $4,087 | $3,977 | 97.3% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 29 | 30 | $3,960 | $2,025 | 51.1% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2021 | 13 | 13 | $1,859 | $1,637 | 88.1% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 17 | 17 | $5,032 | $1,512 | 30.0% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 65 | 65 | $1,950 | $1,248 | 64.0% |
| 0001A | Adm sarscov2 30mcg/0.3ml 1st | Office | 2021 | 59 | 59 | $1,751 | $1,160 | 66.3% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 22 | 52 | $2,550 | $624.76 | 24.5% |
About Dr. David Dellalana, MD
Dr. David Dellalana, MD is a Family Medicine healthcare provider based in Santa Rosa, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/20/2006. The National Provider Identifier (NPI) number assigned to this provider is 1356449029.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Dellalana, MD has received a total of $2,301 in payments from pharmaceutical and medical device companies, with $158.18 received in 2022. These payments were reported across 67 transactions from 19 companies. The most common payment nature is "" ($1,204).
As a Medicare-enrolled provider, Dellalana has provided services to 2,239 Medicare beneficiaries, totaling 6,533 services with total Medicare billing of $280,435. Data is available for 3 years (2020–2022), covering 48 distinct procedure/service records.
Ad
Practice Information
- Specialty Family Medicine
- Location Santa Rosa, CA
- Active Since 09/20/2006
- Last Updated 10/11/2022
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1356449029
Products in Payments
- JARDIANCE (Drug) $175.94
- XARELTO (Drug) $97.09
- AJOVY (Drug) $90.53
- MYRBETRIQ (Drug) $63.22
- EVENITY (Biological) $62.28
- STIOLTO RESPIMAT (Drug) $61.65
- Saxenda (Drug) $58.70
- Ozempic (Drug) $54.62
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $48.10
- CHANTIX (Drug) $41.51
- NEXPLANON (Drug) $41.38
- FLUZONE HIGH-DOSE (Drug) $34.68
- SYMBICORT (Drug) $29.80
- ROTATEQ (Biological) $28.42
- Trintellix (Drug) $19.53
- REXULTI (Drug) $18.02
- TRINTELLIX (Drug) $16.22
- Aimovig (Biological) $16.15
- FARXIGA (Drug) $16.06
- AIMOVIG (Biological) $15.42
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Santa Rosa
Dora Martinez, M.d, M.D
Family Medicine — Payments: $293,315
Family Medicine $293,315
Dr. Amy Shaw, Md, MD
Family Medicine — Payments: $112,442
Family Medicine $112,442
Dr. Marisha Chilcott, M.d, M.D
Family Medicine — Payments: $40,447
Family Medicine $40,447
Johnathan Nguyen
Family Medicine — Payments: $10,780
Family Medicine $10,780
Leo Smith, Md, MD
Family Medicine — Payments: $7,722
Family Medicine $7,722
Dr. Stephen Crane, Md, MD
Family Medicine — Payments: $6,228
Family Medicine $6,228